HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Todd W Bauer Selected Research

Proteins (Proteins, Gene)

1/2019Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth.
7/2005Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Todd W Bauer Research Topics

Disease

53Neoplasms (Cancer)
01/2022 - 08/2002
19Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 07/2005
18Cholangiocarcinoma
01/2022 - 11/2014
18Neoplasm Metastasis (Metastasis)
01/2022 - 04/2005
7Adenocarcinoma
10/2018 - 01/2011
5Infections
01/2018 - 05/2005
4Colorectal Neoplasms (Colorectal Cancer)
02/2013 - 04/2005
4Carcinoma (Carcinomatosis)
11/2007 - 01/2005
3Lymphatic Metastasis
09/2019 - 12/2018
2Heart Arrest (Cardiac Arrest)
11/2018 - 01/2016
2Malnutrition (Nutritional Deficiencies)
11/2018 - 01/2016
2Sepsis (Septicemia)
11/2018 - 06/2015
2Embolism (Embolus)
11/2018 - 01/2016
2Liver Neoplasms (Liver Cancer)
10/2018 - 11/2016
2Klatskin Tumor
01/2018 - 10/2012
2Pancreatic Fistula (Pancreatic Fistulas)
01/2018 - 05/2011
2Neoplasm Micrometastasis
01/2018 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2016 - 03/2002
2Cholangitis
07/2015 - 11/2014
2Melanoma (Melanoma, Malignant)
04/2003 - 08/2002
1Postoperative Pain
11/2022
1Pain (Aches)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
02/2019
1Jaundice (Icterus)
01/2019
1Myocardial Infarction
11/2018
1Hemorrhage
11/2018
1Pancreatic Cyst
01/2018
1Cysts
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Liver Diseases (Liver Disease)
05/2016

Drug/Important Bio-Agent (IBA)

5GemcitabineFDA Link
01/2021 - 09/2005
4LigandsIBA
01/2021 - 04/2005
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2018 - 02/2013
4Insulin-Like Growth Factor I (IGF-1)IBA
10/2007 - 05/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 04/2005
3Pharmaceutical PreparationsIBA
01/2021 - 02/2018
3AntigensIBA
12/2020 - 01/2018
3Monoclonal AntibodiesIBA
02/2018 - 09/2005
3trametinibIBA
01/2016 - 02/2013
3ErbB Receptors (EGF Receptor)IBA
07/2014 - 01/2005
3Phosphotransferases (Kinase)IBA
02/2013 - 01/2005
3IGF Type 1 Receptor (IGF 1 Receptor)IBA
10/2007 - 09/2005
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2006 - 05/2005
3Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2006 - 04/2005
2Opioid Analgesics (Opioids)IBA
11/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
2CarbohydratesIBA
12/2020 - 01/2018
2Tumor Biomarkers (Tumor Markers)IBA
08/2020 - 10/2018
2AlbuminsIBA
04/2020 - 01/2018
2Indicators and Reagents (Reagents)IBA
09/2019 - 03/2002
2Biological ProductsIBA
08/2019 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2005
2AntibodiesIBA
01/2018 - 07/2014
2Lapatinib (GW572016)FDA Link
07/2014 - 02/2013
2Capecitabine (Xeloda)FDA Link
01/2014 - 03/2011
2tyrosine receptor (receptor, tyrosine)IBA
02/2013 - 07/2005
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013 - 01/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 04/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2008 - 08/2002
2Coloring Agents (Dyes)IBA
09/2006 - 03/2002
2Catalytic RNA (Ribozymes)IBA
07/2006 - 05/2005
2Vascular Endothelial Growth Factor BIBA
01/2006 - 07/2005
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
09/2005 - 05/2005
2Urokinase Plasminogen Activator ReceptorsIBA
09/2005 - 05/2005
2Melphalan (Alkeran)FDA LinkGeneric
04/2003 - 08/2002
1TeaIBA
11/2022
1ChromatinIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Floxuridine (FUdR)FDA LinkGeneric
01/2022
1Circulating Tumor DNAIBA
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2021
1MesothelinIBA
01/2021
1Culture MediaIBA
01/2021
1Drug CombinationsIBA
11/2020
1BilirubinIBA
04/2020
1Dynamins (Dynamin)IBA
01/2019
1HexokinaseIBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Hormones (Hormone)IBA
12/2018
1astacinIBA
02/2018
1Immunotoxins (Immunotoxin)IBA
02/2018
1Immunoconjugates (Immunoconjugate)IBA
02/2018
1Carcinoembryonic AntigenIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Clodronic Acid (Clodronate)IBA
01/2018
1thiamine triphosphorate (TTP)IBA
01/2016

Therapy/Procedure

17Therapeutics
01/2019 - 01/2005
12Hepatectomy
01/2022 - 10/2012
8Lymph Node Excision (Lymph Node Dissection)
09/2019 - 08/2009
6Drug Therapy (Chemotherapy)
01/2022 - 01/2005
4Pancreaticoduodenectomy
11/2022 - 06/2015
3Adjuvant Chemotherapy
04/2021 - 10/2017
3Neoadjuvant Therapy
01/2019 - 01/2014
3Pancreatectomy
11/2018 - 05/2011
2Length of Stay
01/2021 - 01/2018
2Radiofrequency Ablation
02/2019 - 11/2014
2Immunotherapy
01/2018 - 01/2016
1Analgesia
11/2022
1Infusion Pumps (Infusion Pump)
01/2022
1Contraindications
08/2017